US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
IO Biotech Inc (IOBT)
IO Biotech Inc (IOBT) ニュース

IOBT

IO Biotech (IOBT)

IO Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IOBT

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/13	06 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOBT	IO Biotech Inc
2024/11/12	21 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/11/12	21 : 05	GlobeNewswire Inc.	IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights	NASDAQ:IOBT	IO Biotech Inc
2024/11/12	06 : 05	GlobeNewswire Inc.	IO Biotech Announces Participation in Upcoming Investor Conferences	NASDAQ:IOBT	IO Biotech Inc
2024/11/08	00 : 00	GlobeNewswire Inc.	IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study	NASDAQ:IOBT	IO Biotech Inc
2024/10/04	22 : 00	GlobeNewswire Inc.	IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2024/09/14	15 : 30	GlobeNewswire Inc.	IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer	NASDAQ:IOBT	IO Biotech Inc
2024/08/31	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/08/31	05 : 05	GlobeNewswire Inc.	IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma	NASDAQ:IOBT	IO Biotech Inc
2024/08/27	05 : 05	GlobeNewswire Inc.	IO Biotech Announces Participation in Upcoming Investor Conferences	NASDAQ:IOBT	IO Biotech Inc
2024/08/14	05 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOBT	IO Biotech Inc
2024/08/13	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/08/13	20 : 05	GlobeNewswire Inc.	IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights	NASDAQ:IOBT	IO Biotech Inc
2024/07/26	05 : 05	GlobeNewswire Inc.	IO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024	NASDAQ:IOBT	IO Biotech Inc
2024/06/12	05 : 44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/06/08	05 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOBT	IO Biotech Inc
2024/06/08	05 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOBT	IO Biotech Inc
2024/05/23	21 : 30	GlobeNewswire Inc.	IO Biotech to Present at Jefferies Global Healthcare Conference	NASDAQ:IOBT	IO Biotech Inc
2024/05/14	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/05/14	21 : 13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOBT	IO Biotech Inc
2024/05/14	20 : 55	GlobeNewswire Inc.	IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights	NASDAQ:IOBT	IO Biotech Inc
2024/04/25	05 : 30	GlobeNewswire Inc.	IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2024/04/15	21 : 30	GlobeNewswire Inc.	IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness	NASDAQ:IOBT	IO Biotech Inc
2024/04/10	01 : 00	GlobeNewswire Inc.	IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103	NASDAQ:IOBT	IO Biotech Inc
2024/04/05	21 : 30	GlobeNewswire Inc.	IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer	NASDAQ:IOBT	IO Biotech Inc
2024/03/12	05 : 56	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IOBT	IO Biotech Inc
2024/03/07	06 : 11	GlobeNewswire Inc.	IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2024/03/06	07 : 17	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:IOBT	IO Biotech Inc
2024/03/06	06 : 46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/03/06	06 : 40	GlobeNewswire Inc.	IO Biotech Announces 2023 Fourth-Quarter and Year-End Results	NASDAQ:IOBT	IO Biotech Inc

Showing the most relevant articles for your search:NASDAQ:IOBT

1 2 3 4 5 次へ >>

US Dollar vs Sterling

US Dollar vs Euro

American Express

Health Care Select Sector

US Dollar vs Yen

Deutsche Telekom (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約